Abstract
Objectives
The vicious cycle of dynapenia and abdominal obesity may have synergistic detrimental impacts on health. We aim to investigate the prospective association between dynapenic abdominal obesity and the risk of heart disease among middle-aged and older adults.
Design
A prospective cohort study.
Setting
English Longitudinal Study of Ageing, 2002–2019.
Participants
A total of 4734 participants aged 50 years and older were included.
Measurements
Individuals were divided into non-dynapenia/non-abdominal obesity (ND/NAO), non-dynapenia/abdominal obesity (ND/AO), dynapenia/non-abdominal obesity (D/NAO), and dynapenia/abdominal obesity (D/AO) according to grip strength and waist circumference at baseline. The Cox proportional hazards models were used to obtain the hazard ratios (HRs) of incident heart disease associated with dynapenia and abdominal obesity after adjusting for potential confounding factors.
Results
During a median follow-up of 9.5 years, 1040 cases of heart disease were recorded. Compared with ND/NAO group, the multivariable HRs were 1.05 (0.92, 1.21) for ND/AO group, 1.31 (0.96, 1.81) for D/NAO group, and 1.39 (1.03, 1.88) for D/AO group. The significant association of D/AO with incident heart disease was detected in women but not in men [HR = 1.55 (1.07, 2.24) and 1.06 (0.60, 1.88), respectively]. Among middle-aged adults, significant associations of D/NAO and D/AO with incident heart disease were observed [HR = 2.46 (1.42, 4.29) and 1.74 (1.02, 2.97), respectively].
Conclusion
Both D/NAO and D/AO might increase the risk of developing heart disease, highlighting the importance of dynapenia and obesity early screening for heart disease prevention.
Similar content being viewed by others
Availability of data and materials: The data involved in this study are freely available from the UK Data Service (https://www.elsa-project.ac.uk/).
Abbreviations
- ELSA:
-
English Longitudinal Study of Ageing
- ND/NAO:
-
nondynapenic/nonabdominal obesity
- D/NAO:
-
dynapenic/nonabdominal obesity
- ND/AO:
-
nondynapenic/abdominal obesity
- D/AO:
-
dynapenic/abdominal obesity.
References
Manini TM, Clark BC. Dynapenia and aging: an update. J Gerontol A Biol Sci Med Sci. Jan 2012;67(1):28–40. doi:https://doi.org/10.1093/gerona/glr010
Rodriguez-Garcia WD, Garcia-Castaneda L, Vaquero-Barbosa N, et al. Prevalence of dynapenia and presarcopenia related to aging in adult community-dwelling Mexicans using two different cut-off points. Eur Geriatr Med. Apr 2018;9(2):219–225. doi:https://doi.org/10.1007/s41999-018-0032-8
Araujo FC, Silva KSD, Ohara DG, Matos AP, Pinto A, Pegorari MS. Prevalence of and risk factors for dynapenic abdominal obesity in community-dwelling older adults: a cross-sectional study. Cien Saude Colet. Feb 2022;27(2):761–769. doi:https://doi.org/10.1590/1413-81232022272.01122021
Kuk JL, Saunders TJ, Davidson LE, Ross R. Age-related changes in total and regional fat distribution. Ageing Res Rev. Oct 2009;8(4):339–48. doi:https://doi.org/10.1016/j.arr.2009.06.001
Hong SH, Choi KM. Sarcopenic Obesity, Insulin Resistance, and Their Implications in Cardiovascular and Metabolic Consequences. Int J Mol Sci. Jan 13 2020;21(2) doi:https://doi.org/10.3390/ijms21020494
Hu L, Huang X, You C, et al. Prevalence of overweight, obesity, abdominal obesity and obesity-related risk factors in southern China. PLoS One. 2017;12(9):e0183934. doi:https://doi.org/10.1371/journal.pone.0183934
Li CW, Yu K, Shyh-Chang N, et al. Pathogenesis of sarcopenia and the relationship with fat mass: descriptive review. J Cachexia Sarcopenia Muscle. Feb 2 2022;doi:https://doi.org/10.1002/jcsm.12901
Oba K, Tamura Y, Ishikawa J, et al. Dynapenic abdominal obesity is associated with mild cognitive impairment in patients with cardiometabolic disease: a cross-sectional study. BMC Geriatr. Mar 28 2022;22(1):255. doi:https://doi.org/10.1186/s12877-022-02948-1
Alexandre TDS, Scholes S, Ferreira Santos JL, Duarte YAO, de Oliveira C. The combination of dynapenia and abdominal obesity as a risk factor for worse trajectories of IADL disability among older adults. Clin Nutr. Dec 2018;37(6 Pt A):2045–2053. doi:https://doi.org/10.1016/j.clnu.2017.09.018
Maximo RO, de Oliveira DC, Ramirez PC, et al. Combination of dynapenia and abdominal obesity affects long-term physical performance trajectories in older adults: Sex differences. Am J Clin Nutr. Jan 31 2022;doi:https://doi.org/10.1093/ajcn/nqac023
de Oliveira Maximo R, de Oliveira DC, Ramirez PC, et al. Dynapenia, abdominal obesity or both: which accelerates the gait speed decline most? Age Ageing. Sep 11 2021;50(5):1616–1625. doi:https://doi.org/10.1093/ageing/afab093
Zhang L, Liu S, Wang W, et al. Dynapenic abdominal obesity and the effect on long-term gait speed and falls in older adults. Clin Nutr. Jan 2022;41(1):91–96. doi:https://doi.org/10.1016/j.clnu.2021.11.011
Dowling L, Cuthbertson DJ, Walsh JS. Reduced muscle strength (dynapenia) in women with obesity confers a greater risk of falls and fractures in the UK Biobank. Obesity (Silver Spring). Feb 2023;31(2):496–505. doi:https://doi.org/10.1002/oby.23609
Rossi AP, Bianchi L, Volpato S, et al. Dynapenic Abdominal Obesity as a Predictor of Worsening Disability, Hospitalization, and Mortality in Older Adults: Results From the InCHIANTI Study. J Gerontol A Biol Sci Med Sci. Aug 1 2017;72(8):1098–1104. doi:https://doi.org/10.1093/gerona/glw203
Rossi AP, Fantin F, Caliari C, et al. Dynapenic abdominal obesity as predictor of mortality and disability worsening in older adults: A 10-year prospective study. Clin Nutr. Feb 2016;35(1):199–204. doi:https://doi.org/10.1016/j.clnu.2015.02.005
Senechal M, Dionne IJ, Brochu M. Dynapenic abdominal obesity and metabolic risk factors in adults 50 years of age and older. J Aging Health. Aug 2012;24(5):812–26. doi:https://doi.org/10.1177/0898264312440324
Kowall B. Lower body muscle strength, dynapenic obesity and risk of type 2 diabetes -longitudinal results on the chair-stand test from the Survey of Health, Ageing and Retirement in Europe (SHARE). BMC Geriatr. Dec 1 2022;22(1):924. doi:https://doi.org/10.1186/s12877-022-03647-7
Ramirez PC, de Oliveira DC, de Oliveira Maximo R, et al. Is dynapenic abdominal obesity a risk factor for cardiovascular mortality? A competing risk analysis. Age Ageing. Jan 8 2023;52(1)doi:https://doi.org/10.1093/ageing/afac301
Celis-Morales CA, Welsh P, Lyall DM, et al. Associations of grip strength with cardiovascular, respiratory, and cancer outcomes and all cause mortality: prospective cohort study of half a million UK Biobank participants. BMJ. May 8 2018;361:k1651. doi:https://doi.org/10.1136/bmj.k1651
Xue R, Li Q, Geng Y, Wang H, Wang F, Zhang S. Abdominal obesity and risk of CVD: a dose-response meta-analysis of thirty-one prospective studies. Br J Nutr. Nov 14 2021;126(9):1420–1430. doi:https://doi.org/10.1017/S0007114521000064
Steptoe A, Breeze E, Banks J, Nazroo J. Cohort profile: the English longitudinal study of ageing. Int J Epidemiol. Dec 2013;42(6):1640–8. doi:https://doi.org/10.1093/ije/dys168
Wang X, Jiang J, Hu Y, Qin LQ, Hao Y, Dong JY. Art Engagement and Risk of Type 2 Diabetes: Evidence From the English Longitudinal Study of Ageing. Int J Public Health. 2023;68:1605556. doi:https://doi.org/10.3389/ijph.2023.1605556
Bhasin S, Travison TG, Manini TM, et al. Sarcopenia Definition: The Position Statements of the Sarcopenia Definition and Outcomes Consortium. J Am Geriatr Soc. Jul 2020;68(7):1410–1418. doi:https://doi.org/10.1111/jgs.16372
Valtorta NK, Kanaan M, Gilbody S, Hanratty B. Loneliness, social isolation and risk of cardiovascular disease in the English Longitudinal Study of Ageing. Eur J Prev Cardiol. Sep 2018;25(13):1387–1396. doi:https://doi.org/10.1177/2047487318792696
Clark BC, Manini TM. What is dynapenia? Nutrition. May 2012;28(5):495–503. doi:https://doi.org/10.1016/j.nut.2011.12.002
Jun JE, Kang M, Jin SM, et al. Additive effect of low skeletal muscle mass and abdominal obesity on coronary artery calcification. Eur J Endocrinol. May 6 2021;184(6):867–877. doi:https://doi.org/10.1530/EJE-20-0885
Xia MF, Chen LY, Wu L, et al. Sarcopenia, sarcopenic overweight/obesity and risk of cardiovascular disease and cardiac arrhythmia: A cross-sectional study. Clin Nutr. Feb 2021;40(2):571–580. doi:https://doi.org/10.1016/j.clnu.2020.06.003
Fukuda T, Bouchi R, Takeuchi T, et al. Sarcopenic obesity assessed using dual energy X-ray absorptiometry (DXA) can predict cardiovascular disease in patients with type 2 diabetes: a retrospective observational study. Cardiovasc Diabetol. Apr 10 2018;17(1):55. doi:https://doi.org/10.1186/s12933-018-0700-5
Evans K, Abdelhafiz D, Abdelhafiz AH. Sarcopenic obesity as a determinant of cardiovascular disease risk in older people: a systematic review. Postgrad Med. Nov 2021;133(8):831–842. doi:https://doi.org/10.1080/00325481.2021.1942934
Farmer RE, Mathur R, Schmidt AF, et al. Associations Between Measures of Sarcopenic Obesity and Risk of Cardiovascular Disease and Mortality: A Cohort Study and Mendelian Randomization Analysis Using the UK Biobank. J Am Heart Assoc. Jul 2 2019;8(13):e011638. doi:https://doi.org/10.1161/JAHA.118.011638
Kim JH, Cho JJ, Park YS. Relationship between sarcopenic obesity and cardiovascular disease risk as estimated by the Framingham risk score. J Korean Med Sci. Mar 2015;30(3):264–71. doi:https://doi.org/10.3346/jkms.2015.30.3.264
Gubelmann C, Vollenweider P, Marques-Vidal P. Association of grip strength with cardiovascular risk markers. Eur J Prev Cardiol. Mar 2017;24(5):514–521. doi:https://doi.org/10.1177/2047487316680695
Roh E, Choi KM. Health Consequences of Sarcopenic Obesity: A Narrative Review. Front Endocrinol (Lausanne). 2020;11:332. doi:https://doi.org/10.3389/fendo.2020.00332
RB VANH, Cushman M, Schlueter EF, Allison MA. Abdominal Muscle Density Is Inversely Related to Adiposity Inflammatory Mediators. Med Sci Sports Exerc. Jul 2018;50(7):1495–1501. doi:https://doi.org/10.1249/MSS.0000000000001570
Schrager MA, Metter EJ, Simonsick E, et al. Sarcopenic obesity and inflammation in the InCHIANTI study. J Appl Physiol (1985). Mar 2007;102(3):919–25. doi:https://doi.org/10.1152/japplphysiol.00627.2006
Bellanti F, Romano AD, Lo Buglio A, et al. Oxidative stress is increased in sarcopenia and associated with cardiovascular disease risk in sarcopenic obesity. Maturitas. Mar 2018;109:6–12. doi:https://doi.org/10.1016/j.maturitas.2017.12.002
Atkins JL, Whincup PH, Morris RW, Lennon LT, Papacosta O, Wannamethee SG. Sarcopenic obesity and risk of cardiovascular disease and mortality: a population-based cohort study of older men. J Am Geriatr Soc. Feb 2014;62(2):253–60. doi:https://doi.org/10.1111/jgs.12652
Terauchi M, Odai T, Hirose A, Kato K, Akiyoshi M, Miyasaka N. Muscle and joint pains in middle-aged women are associated with insomnia and low grip strength: a cross-sectional study. J Psychosom Obstet Gynaecol. Mar 2020;41(1):15–21. doi:https://doi.org/10.1080/0167482X.2018.1530211
Shim J, Yoo HJ. Effects of Handgrip Strength on 10-Year Cardiovascular Risk among the Korean Middle-Aged Population: The Korea National Health and Nutrition Examination Survey 2014. Healthcare (Basel). Nov 4 2020;8(4)doi:https://doi.org/10.3390/healthcare8040458
Park J, Park H. Muscle strength and carotid artery flow velocity is associated with increased risk of atherosclerosis in adults. Cardiol J. 2017;24(4):385–392. doi:https://doi.org/10.5603/CJ.a2017.0007
Acknowledgements: The authors would like to thank the UK data archive and ELSA research group for providing the data. The ELSA study was developed by University College London, the Institute of Fiscal Studies and the National Centre for Social Research. The developers and funders of ELSA had no roles in data analysis, interpretation and manuscript writing.
Funding
Funding: This work was supported by China Postdoctoral Science Foundation (grant no. 2023M730113 to X.Wang); National key research and development program of China (grant number 2022YFC3600804 to Y. Hao). The funders were not involved in the design, implementation, assessment, analysis or interpretation of the data; or the decision to submit the manuscript for publication.
Author information
Authors and Affiliations
Contributions
Authors’ contributions: Conceptualization: X. Wang and J-Y. Dong; Methodology: L-Q. Qin and Y. Hu; Formal Analysis: X. Wang and J-Y. Dong; Investigation: J.J and W. Hu; Writing - Original Draft Preparation: X. Wang; Writing - Review & Editing: J.J, W. Hu, L-Q. Qin, Y. Hu, Y. Hao, and J-Y. Dong. All authors saw and approved the final version and no other person made a substantial contribution to the paper.
Corresponding authors
Ethics declarations
Ethics approval and consent to participate: ELSA has obtained ethical approval from the National Research Ethics Service (MREC/01/2/91). All the participants have completed informed consent before the surveys.
Competing interests: No potential conflicts of interest relevant to this article were reported.
Additional information
Consent for publication: Not applicable.
Electronic Supplementary Material
Rights and permissions
About this article
Cite this article
Wang, X., Jiang, J., Hu, W. et al. Dynapenic Abdominal Obesity and Risk of Heart Disease among Middle-Aged and Older Adults: A Prospective Cohort Study. J Nutr Health Aging 27, 752–758 (2023). https://doi.org/10.1007/s12603-023-1975-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12603-023-1975-0